- 期刊
Effects of Clopidogrel and Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Bare Metal Stent Implantation: A Nationwide Cohort Study
摘要
Background: To investigate whether there is an increased risk of cardiovascular (CV) events in patients with diabetes associated with adding proton pump inhibitors (PPIs) to clopidogrel (CLO) therapy after bare-metal stent (BMS) deployment. Methods: We used the National Health Insurance Research Database to conduct this retrospective cohort study. We enrolled 6,757 patients with diabetes who underwent BMS deployment and received CLO with/without PPIs for 90 days (6,243 in the CLO subgroup and 514 in the CLO plus PPI subgroup). The endpoints were acute coronary syndrome and re-admission for revascularization (PCI or coronary artery bypass graft surgery) after 3, 6, and 12 months. Results: The patients who received CLO with PPIs had no significant increase in adverse CV events compared to those without PPIs within 1 year after BMS deployment [3-month hazard ratio (HR) = 0.87, 95% confidence interval (CI), 0.65-1.15; 6 months, HR = 0.95, 95% CI, 0.78-1.15; 1 year, HR = 0.60, 95% CI, 0.81-1.12]. Conclusions: In patients with diabetes undergoing BMS deployment, there was no evidence of an increased risk of CV events among concomitant users of CLO and PPIs. Our results indicate that the use of PPIs may not modify the protective effect of CLO after BMS implantation.
延伸閱讀
- 鄭閎文（2022）。Sodium-glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors Influence the Risk of New-onset Atrial Fibrillation in Patients With Type II Diabetes Mellitus〔碩士論文，中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/csmu202200080
- Chiang, T. T., Chen, J. H., Sun, J. R., Yin, T., Wang, Y. C., Yang, Y. S., Lin, T. Y., Chiu, S. K., Yeh, K. M., Wang, N. C., Lin, J. C., & Chang, F. Y. (2019). Effect of Prior Antiplatelet Therapy on Major Adverse Cardiac Events in Patients Diagnosed with Infective Endocarditis: Population‑Based Retrospective Cohort Study. Journal of Medical Sciences, 39(1), 36-42. https://doi.org/10.4103/jmedsci.jmedsci_67_18
- Peng, C. H., Huang, T. P., Chen, Y. H., Hsu, C. H., & Cheng, I. L. (2022). Clinical Efficacy and Safety of Reduced-Dose Prasugrel versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Acta Cardiologica Sinica, 38(4), 425-434. https://doi.org/10.6515/ACS.202207_38(4).20220319A
- 蔣恆斌（2017）。Relationships between Dipeptidyl Peptidase-4 Inhibitors and the Risk, Cost and Length of Stay of Hospitalization for Heart Failure in Patients with Type 2 Diabetes and Chronic Kidney Disease: a Nationwide Population-based Study〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-2406201713294600
- Lu, Y. Y., Wang, C. L., Chang, S. H., Hsiao, F. C., Huang, Y. C., Huang, Y. T., Liao, T. W., & Chu, P. H. (2022). Dual versus Single Antiplatelet Therapy in Medically Treated Acute Myocardial Infarction Patients with Baseline Thrombocytopenia - Insights from a Multi-Institute Cohort Study. Acta Cardiologica Sinica, 38(4), 443-454. https://doi.org/10.6515/ACS.202207_38(4).20220109A